Responses to Interferon of LM Cells Growing Continuously in the Absence of Serum and Exogenous Lipids
SUMMARY Mouse fibroblast LM cells growing continuously in the absence of serum and exogenous lipids are proposed as a model for studying interferon action. Several of its activities, namely the inhibition of virus and cell growth, and the increased cytotoxicity of poly(rI).poly(rC), are shown to be potentiated in such conditions. Since cells cultured under these conditions are devoid of precursors of prostaglandin biosynthesis, the data suggest that none of the three effects of interferon depends on active prostaglandin synthesis.
Interferons have various biological activities (Gresser, 1977; Stewart, 1979; TaylorPapadimitriou, 1980) . Among them the antiviral activity, the inhibitory effect on cell multiplication and the activation of natural killer cell have been most intensively investigated. Interferon has been shown to modify cell structure and metabolism in various ways; for example it causes changes in the plasma membrane, in the organization of the cytoskeleton (Pfeffer et al., 1980) and in the metabolism of lipids (Apostolov & Barker, 1981 ; and also induces new proteins and enzyme activities (Lengyel, 1981) . The fact that interferons exert multiple biological activities and do so at very low doses allows us to classify them as hormone-like substances. As is the case for many hormones, it would be of interest if one could assess the cellular effects of interferons under defined conditions of lipid and protein, a condition which is not fulfilled in most experimental systems where cells are growing in the presence of serum (Barnes & Sato, 1980) . Indeed, several examples indicate that the effect of interferon is modified by the environment of the cells, e.g. by the removal of arginine from the medium (Lee & Rozee, 1975) , the influence of mitogenic factors (Taylor-Papadimitriou et al., 1981) or the reduction of the amount of serum in a serum-dependent cell culture (Gresser et al., 1970; Kading et al., 1978) .
This report presents a cellular model which allows the responses of cells to interferon to be investigated in a chemically controlled environment. LM cells have been chosen because of their ability to grow continuously in a simple serum-free medium. This cell line has been widely investigated for studies on the metabolism of lipids (Ferguson et al., 1975; Saito et al., 1977; Schroeder & Vagelos, 1976) and it is derived from the L929 cell line which has been studied extensively for its responses to interferons.
We show in this paper that several interferon-mediated responses are increased even though the ability of the cells to grow in serum-free, lipid-free conditions is not altered. These responses include the antiviral effect and poly(rI).poly(rC) cytotoxicity (Stewart et al., 1972) in addition to the inhibitory effect on growth. Further investigations, however, are required to unravel the origin of the observed increases. In addition, our data argue against a recent proposal (Chandrabose et al., 1981b; Pottathil et al., 1980) that the fatty acid cyclooxygenase (8,11,14-eicosatrienoate, hydrogen donor :oxygen oxidoreductase, EC 1.14.99.1) plays a major role in the development of the antiviral state.
LM cells were obtained from the ATCC (CCL I-2). Marine fibroblastic interferon (IFN) (induced by Newcastle disease virus in C243 cells and partially purified up to a specific activity of 107 units/mg protein) was a kind gift of Dr I. Gresser (Institut de Recherches Scientifiques sur le Cancer, Villejuif, France). Cells were grown in RPMI 1640 medium (Eurobio) supplemented with bovine albumin (essentially lipid-free, Sigma A7511 ; 100 ~tg/ml), pyruvate (1 mM), vitamin B12 (0.825 ~tg/ml), glutamine (2 mM), penicillin (50 U/ml) and streptomycin ( .poly(rC) cytotoxicity. Cells (3 × 103) were plated in 5 cm Petri dishes in the presence of 1000 U/ml interferon when indicated. Twenty h later, poly(rI).poly(rC) was added in serum-free conditions. The medium was withdrawn 90 min later and the cells further incubated in their former medium. After 3 days, all media were replaced by fresh medium containing serum. Colonies were counted under the microscope between 2 and 4 days later. Plating efficiency in control dishes was found to be approx. 25%. The media used were serum-free (O), serum-free + IFN (O), serum-enriched (A) and serum-enriched + IFN (A). * Linbro dishes were inoculated with 2 × 105 cells/ml/well in the presence or in the absence of cyclooxygenase inhibitors, as indicated. After 24 h exposure the cultures were challenged with VSV (m.o.i. 0.1) and virus yields titrated by the dilution method. The significant difference at probability level 0.05 was + 0.46, CO2 atmosphere at 37 °C; this medium will be referred to as serum-free. A concentration of 4~o (v/v) donor horse serum (Flow Laboratories) was used when indicated. The fatty acid composition of total lipids was determined by gas-liquid chromatography (Erba Science Model 2900 Fractovap) using a glass capillary column (25.5 m length, phase SE30; lipid extraction following Folch et al., 1957) . No trace amount of any essential lipid and no prostaglandin precursors were detected in the medium, in the concentrated albumin or in the cells; under our conditions 10 ng of a specific fatty acid is the minimum amount which can be detected.
OO
Three responses to interferon, namely the growth-inhibitory effect (Fig. 1 a) , the antiviral effect ( Fig. 1 b) and the lysis of interferon-treated cells after exposure to poly(rI), poly(rC) (Fig.  1 c) , have been analysed in medium containing serum and in long-term, serum-free culture. These three responses were found to be increased in serum-free conditions. The growthinhibitory effect was not due to cell death in these experimental conditions (data not shown). We have verified that the lower virus production in serum-free medium as compared to medium containing serum is not due to a low spontaneous production of interferon by using antiinterferon antibodies (Gresser et al., 1976 ) (data not shown). Our results do not contradict previous reports on different serum-dependent cellular systems which have firstly pointed out that removal of serum increases the inhibition of cell growth by interferon (Gresser et al., 1970; Kading et al., 1978; Tovey & Brouty-Boy6, 1979) and secondly demonstrated that growth factors antagonize the inhibitory effect of interferon on cell growth and virus production (Lin et al., 1980; Oleszak & Inglot, 1980; Pfeffer et al., 1980; Taylor-Papadimitriou, et al., 1981) . We should emphasize that these increases were obtained while untreated cells were dividing normally in our serum-free conditions. This is at variance with previous studies using serum-dependent cell lines where serum depletion dramatically slowed down the cell cycle. Moreover, it is worth considering that interferon modifies the metabolism of lipids (Apostolov & Barker, 1981; Chandrabose et al,, 1981a) while, on the other hand, modifications of the lipid environment influence LM cell growth and vesicular stomatitis virus development (Doi et al., 1978 ; Maeda et al., 1980) . The increased toxicity of poly(rI).poly(rC) for interferon-treated cells described in this report and reported previously (Wallach & Revel, 1979) provides a way of isolation of resistant variants (T. Faure et al., unpublished results). We believe that the unsuccessful attempts to isolate such variants have been hampered by the low cytotoxicity obtained in the presence of serum (Cooper et al., 1979; Emeny & Morgan, 1979) .
Pretreatment of L929 cells with inhibitors of fatty acid cyclooxygenase, such as oxyphenbutazone and indomethacin, has recently been shown to inhibit significantly the development of an antiviral state upon exposure to interferon (Pottathil et al., 1980) . This result appeared to be in conflict with our observations that the interferon-mediated antiviral response is increased in a lipid-deprived medium. Indeed, fatty acid cyclooxygenase catalyses the first step in the synthesis of prostaglandins and mammalian cells are unable to synthesize de novo the linoleic acid and the c~-linolenic acid precursors of cyclooxygenase substrates (Jeffcoat, 1979) . We know that the precursors are provided by the serum which normally feeds the cells and we have verified that the serum-free medium does not contain any prostaglandin precursors (data not shown).
In order to check for a possible involvement of cyclooxygenase in the absence of prostaglandin synthesis we have assayed the effect of cyclooxygenase inhibitors on the antiviral effect of interferon. The previously described (Pottathil et al., 1980) partial inhibition by oxyphenbutazone of the antiviral effect of interferon on L929 cells was verified (data not shown).When used at 4 ~tM, the maximum non-toxic dose in our system, oxyphenbutazone did not inhibit the development of the antiviral state in LM cells (Table 1) . Moreover, indomethacin, which has been reported to be more active than oxyphenbutazone in inhibiting cyclooxygenase activity in many cell types (Flower & Vane, 1974) , was also ineffective at 10 ~t~. This dose is not toxic and the occasional instability of the drug is not encountered in serum-free conditions as described previously (Brune et al., 1981) .
Neither active prostaglandin synthesis nor a functional fatty acid cyclooxygenase has been found to be essential for the development of an interferon-mediated antiviral state in serum-free conditions. Whether the situation is different for cells growing in the presence of serum, however, cannot be excluded (Pottathil et al., 1980; Sayama et al., 1981) . Furthermore, these experiments suggest that the growth inhibitory effect of interferon and the cell lysis obtained by the combined treatment of interferon and poly(rI)-poly(rC) are not, as recently postulated (Wallach & Revel, 1979) , mediated by prostaglandin synthesis.
Taken together, these observations indicate that LM cells provide a suitable system for studying the interactions between the lipid and protein cell environment and interferon action and for the isolation of mutants.
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